{"kind": "industries", "kind_singular": "industry", "raw_label": "Biotechnology", "label": "Biotechnology", "flag": "", "score": 46.0, "tone": "neutral", "state": {"label": "More negative than positive", "tone": "negative", "breadth": 36, "summary": "Negative company scores outnumber positive ones, but they do not yet dominate the whole group."}, "headline": "Company news is mixed", "summary": "Positive and negative company readings are balancing each other. The company list below shows where they differ.", "scope_note": "This is a global view using qualified companies from every covered country.", "reliable": true, "confidence": 49, "coverage": 2, "coverage_display": "1.5", "universe_count": 1189, "qualified_count": 18, "issuer_count": 18, "record_count": 1140, "excluded_count": 1122, "articles": 758, "direct_articles": 758, "direct_share": 100, "source_count": 227, "signal_strength": 8, "dispersion": 11.7, "tone_mix": [{"label": "Constructive", "tone": "positive", "count": 5, "share": 27.8, "start": 0.0, "end": 27.8}, {"label": "Balanced", "tone": "neutral", "count": 3, "share": 16.7, "start": 27.8, "end": 44.5}, {"label": "Cautious", "tone": "negative", "count": 10, "share": 55.6, "start": 44.5, "end": 100.1}], "score_distribution": [{"label": "Strong caution", "count": 3, "tone": "negative", "bar": 43, "share": 17}, {"label": "Cautious", "count": 7, "tone": "negative", "bar": 100, "share": 39}, {"label": "Balanced", "count": 3, "tone": "neutral", "bar": 43, "share": 17}, {"label": "Constructive", "count": 5, "tone": "positive", "bar": 71, "share": 28}, {"label": "Strongly constructive", "count": 0, "tone": "positive", "bar": 0, "share": 0}], "confidence_mix": [{"label": "High confidence", "tone": "positive", "count": 0, "width": 0}, {"label": "Usable evidence", "tone": "neutral", "count": 7, "width": 64}, {"label": "Developing", "tone": "negative", "count": 11, "width": 100}], "reaction_rows": [{"label": "Confirmed by price", "tone": "positive", "count": 10, "share": 56}, {"label": "News-price disagreement", "tone": "negative", "count": 2, "share": 11}, {"label": "Cautious news absorbed", "tone": "positive", "count": 0, "share": 0}, {"label": "No decisive price test", "tone": "neutral", "count": 6, "share": 33}], "market_context": {"measured": 18, "one_week_median": -0.9, "four_week_median": -12.7, "positive_one_week_share": 28, "trend_active_share": 44, "above_fair_value_share": 44, "fair_value_median": -5.3}, "history": {"available": true, "rows": [{"week": "2026-07-06", "label": "06 Jul", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 42.0, "score_y": null, "breadth_y": null}, {"week": "2026-07-13", "label": "13 Jul", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 118.3, "score_y": null, "breadth_y": null}, {"week": "2026-07-20", "label": "20 Jul", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 194.7, "score_y": null, "breadth_y": null}, {"week": "2026-07-27", "label": "27 Jul", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 271.0, "score_y": null, "breadth_y": null}, {"week": "2026-08-03", "label": "03 Aug", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 347.3, "score_y": null, "breadth_y": null}, {"week": "2026-08-10", "label": "10 Aug", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 423.7, "score_y": null, "breadth_y": null}, {"week": "2026-08-17", "label": "17 Aug", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 500.0, "score_y": null, "breadth_y": null}, {"week": "2026-08-24", "label": "24 Aug", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 576.3, "score_y": null, "breadth_y": null}, {"week": "2026-08-31", "label": "31 Aug", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 652.7, "score_y": null, "breadth_y": null}, {"week": "2026-09-07", "label": "07 Sep", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 729.0, "score_y": null, "breadth_y": null}, {"week": "2026-09-14", "label": "14 Sep", "score": null, "breadth": null, "count": 0, "tone": "neutral", "x": 805.3, "score_y": null, "breadth_y": null}, {"week": "2026-09-21", "label": "21 Sep", "score": 48.0, "breadth": 50.0, "count": 4, "tone": "neutral", "x": 881.7, "score_y": 138.6, "breadth_y": 135.0}, {"week": "2026-09-28", "label": "28 Sep", "score": 44.9, "breadth": 34.4, "count": 16, "tone": "neutral", "x": 958.0, "score_y": 144.3, "breadth_y": 163.4}], "tone_path": "M881.7,138.6 L958.0,144.3", "breadth_path": "M881.7,135.0 L958.0,163.4", "tone_points": "", "breadth_points": "", "start": "06 Jul", "mid": "17 Aug", "end": "28 Sep", "sample": 18, "momentum": {"label": "History building", "tone": "neutral", "delta": null, "matched": 0, "recent": 44.9, "prior": null}}, "changes": {"days": 7, "cutoff": "2026-09-22T04:25:10.768Z", "count": 0, "eligible": 18, "delta": null, "improving": 0, "weakening": 0, "stable": 0, "leaders": [], "laggards": []}, "matrix": {"columns": [{"label": "Developing", "range": "35\u201349"}, {"label": "Usable", "range": "50\u201369"}, {"label": "High", "range": "70\u2013100"}], "rows": [{"tone": "positive", "label": "Constructive", "cells": [{"count": 5, "share": 27.8, "opacity": 0.211, "confidence": "Developing"}, {"count": 0, "share": 0.0, "opacity": 0, "confidence": "Usable"}, {"count": 0, "share": 0.0, "opacity": 0, "confidence": "High"}]}, {"tone": "neutral", "label": "Balanced", "cells": [{"count": 3, "share": 16.7, "opacity": 0.143, "confidence": "Developing"}, {"count": 0, "share": 0.0, "opacity": 0, "confidence": "Usable"}, {"count": 0, "share": 0.0, "opacity": 0, "confidence": "High"}]}, {"tone": "negative", "label": "Cautious", "cells": [{"count": 3, "share": 16.7, "opacity": 0.143, "confidence": "Developing"}, {"count": 7, "share": 38.9, "opacity": 0.28, "confidence": "Usable"}, {"count": 0, "share": 0.0, "opacity": 0, "confidence": "High"}]}], "total": 18, "high_directional": 0}, "primary": {"rows": [{"label": "United States", "raw_label": "US", "flag": "\ud83c\uddfa\ud83c\uddf8", "score": 46.0, "tone": "neutral", "confidence": 49, "count": 18, "share": 100.0, "direct_share": 100, "detail_url": "/sentiment/countries/us/", "rank": 1, "width": 100}], "leaders": [{"label": "United States", "raw_label": "US", "flag": "\ud83c\uddfa\ud83c\uddf8", "score": 46.0, "tone": "neutral", "confidence": 49, "count": 18, "share": 100.0, "direct_share": 100, "detail_url": "/sentiment/countries/us/", "rank": 1, "width": 100}], "laggards": [{"label": "United States", "raw_label": "US", "flag": "\ud83c\uddfa\ud83c\uddf8", "score": 46.0, "tone": "neutral", "confidence": 49, "count": 18, "share": 100.0, "direct_share": 100, "detail_url": "/sentiment/countries/us/", "rank": 1, "width": 100}], "count": 1, "thin_excluded": 0, "minimum": 5}, "secondary": {"rows": [{"label": "Healthcare", "raw_label": "Healthcare", "flag": "", "score": 46.0, "tone": "neutral", "confidence": 49, "count": 18, "share": 100.0, "direct_share": 100, "detail_url": "/sentiment/sectors/healthcare/", "rank": 1, "width": 100}], "leaders": [{"label": "Healthcare", "raw_label": "Healthcare", "flag": "", "score": 46.0, "tone": "neutral", "confidence": 49, "count": 18, "share": 100.0, "direct_share": 100, "detail_url": "/sentiment/sectors/healthcare/", "rank": 1, "width": 100}], "laggards": [{"label": "Healthcare", "raw_label": "Healthcare", "flag": "", "score": 46.0, "tone": "neutral", "confidence": 49, "count": 18, "share": 100.0, "direct_share": 100, "detail_url": "/sentiment/sectors/healthcare/", "rank": 1, "width": 100}], "count": 1, "thin_excluded": 0, "minimum": 5}, "primary_label": "Countries in this industry", "secondary_label": "Sectors containing this industry", "rank": 84, "peer_count": 102, "rank_percentile": 19, "peers": [{"label": "Specialty Business Services", "raw_label": "Specialty Business Services", "score": 65.6, "average_score": 65.4, "confidence": 46, "confidence_label": "building confidence", "tone": "positive", "bar": 65.6, "count": 5, "issuer_count": 2, "universe_count": 378, "coverage": 1, "coverage_display": "1.3", "articles": 228, "direct_articles": 228, "source_count": 52, "positive": 5, "neutral": 0, "negative": 0, "latest": "2026-09-29T02:19:41.259Z", "weight": 2.22, "signal_strength": 31, "direct_share": 100, "confirmed": 3, "disagreement": 0, "absorbed": 0, "stretch_risk": 1, "quality": "limited company sample", "url": "/global/sectors/industrials/specialty-business-services/", "detail_url": "/sentiment/industries/specialty-business-services/", "ticker_snapshot_ids": [2591415, 2591451, 2591401, 2594481, 2591411], "tickers": [{"uuid": "fcfd12f5-3743-47cf-a684-3c70a943c46c", "symbol": "CTAS", "name": "Cintas Corporation", "score": 71, "tone": "positive", "country": "US", "exchange": "NASDAQ", "market": {"country_code": "US", "country": "United States", "flag": "\ud83c\uddfa\ud83c\uddf8", "exchange": "NASDAQ", "url": "/listings/?exchange=NASDAQ", "label": "NASDAQ \u00b7 United States", "aria": "Open NASDAQ exchange listings for United States"}, "sector": "Industrials", "industry": "Specialty Business Services", "headline": "Cintas (CTAS)\u2019s Strong Quarter Is Clear. The Valuation Is the Harder Question", "source": "finance.yahoo.com", "articles": 106, "total_matched": 106, "story_count": 106, "direct_articles": 106, "direct_share": 95, "confidence": 78, "confidence_label": "solid confidence", "effective_articles": 30.12, "dispersion": 13, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-29T00:52:04.218Z", "weight": 1.3951, "event_label": "Earnings", "reaction_label": "News confirmed by price", "reaction_class": "confirmed_positive", "reaction_summary": "Constructive news tone is being confirmed by positive weekly price action.", "reaction_tone": "positive", "trend_label": "Trend active", "one_week_move": 1.1, "four_week_move": -2.1, "fair_value_gap": 8.0, "url": "/sentiment/fcfd12f5-3743-47cf-a684-3c70a943c46c/", "chart_url": "/terminal/fcfd12f5-3743-47cf-a684-3c70a943c46c/", "sector_url": "/structure/us/industrials/", "industry_url": "/structure/us/industrials/specialty-business-services/"}, {"uuid": "2b74f899-4ffc-4142-a9af-7ee7eb9d195c", "symbol": "CTAS", "name": "Cintas Corporation", "score": 67, "tone": "positive", "country": "AT", "exchange": "VIE", "market": {"country_code": "AT", "country": "Austria", "flag": "\ud83c\udde6\ud83c\uddf9", "exchange": "VIE", "url": "/listings/?exchange=VIE", "label": "VIE \u00b7 Austria", "aria": "Open VIE exchange listings for Austria"}, "sector": "Industrials", "industry": "Specialty Business Services", "headline": "Cintas (CTAS)\u2019s Strong Quarter Is Clear. The Valuation Is the Harder Question", "source": "finance.yahoo.com", "articles": 39, "total_matched": 39, "story_count": 39, "direct_articles": 39, "direct_share": 85, "confidence": 50, "confidence_label": "building confidence", "effective_articles": 12.77, "dispersion": 12, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-29T00:54:31.198Z", "weight": 1.137, "event_label": "Earnings", "reaction_label": "Balanced read", "reaction_class": "balanced", "reaction_summary": "News tone and price action are not far from neutral.", "reaction_tone": "neutral", "trend_label": "Trend active", "one_week_move": 0.9, "four_week_move": -1.2, "fair_value_gap": 5.5, "url": "/sentiment/2b74f899-4ffc-4142-a9af-7ee7eb9d195c/", "chart_url": "/terminal/2b74f899-4ffc-4142-a9af-7ee7eb9d195c/", "sector_url": "/structure/at/industrials/", "industry_url": "/structure/at/industrials/specialty-business-services/"}, {"uuid": "17a4311e-e086-4916-b2cf-fd7145c9a5a6", "symbol": "CIT", "name": "Cintas Corporation", "score": 65, "tone": "positive", "country": "DE", "exchange": "GER", "market": {"country_code": "DE", "country": "Germany", "flag": "\ud83c\udde9\ud83c\uddea", "exchange": "GER", "url": "/listings/?exchange=GER", "label": "GER \u00b7 Germany", "aria": "Open GER exchange listings for Germany"}, "sector": "Industrials", "industry": "Specialty Business Services", "headline": "Cintas (CTAS)\u2019s Strong Quarter Is Clear. The Valuation Is the Harder Question", "source": "finance.yahoo.com", "articles": 37, "total_matched": 37, "story_count": 37, "direct_articles": 37, "direct_share": 83, "confidence": 45, "confidence_label": "building confidence", "effective_articles": 10.27, "dispersion": 13, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-29T00:51:13.167Z", "weight": 1.0909, "event_label": "Earnings", "reaction_label": "News confirmed by price", "reaction_class": "confirmed_positive", "reaction_summary": "Constructive news tone is being confirmed by positive weekly price action.", "reaction_tone": "positive", "trend_label": "Trend active", "one_week_move": 1.9, "four_week_move": 2.8, "fair_value_gap": -47.2, "url": "/sentiment/17a4311e-e086-4916-b2cf-fd7145c9a5a6/", "chart_url": "/terminal/17a4311e-e086-4916-b2cf-fd7145c9a5a6/", "sector_url": "/structure/de/industrials/", "industry_url": "/structure/de/industrials/specialty-business-services/"}, {"uuid": "7db6254f-478f-428b-9188-253a56f5a3d8", "symbol": "AZZ", "name": "AZZ Incorporated", "score": 64, "tone": "positive", "country": "US", "exchange": "NYSE", "market": {"country_code": "US", "country": "United States", "flag": "\ud83c\uddfa\ud83c\uddf8", "exchange": "NYSE", "url": "/listings/?exchange=NYSE", "label": "NYSE \u00b7 United States", "aria": "Open NYSE exchange listings for United States"}, "sector": "Industrials", "industry": "Specialty Business Services", "headline": "Here's Why AZZ (AZZ) Fell More Than Broader Market", "source": "Zacks", "articles": 22, "total_matched": 22, "story_count": 22, "direct_articles": 22, "direct_share": 97, "confidence": 42, "confidence_label": "building confidence", "effective_articles": 2.56, "dispersion": 15, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-29T02:19:41.259Z", "weight": 1.0489, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_class": "confirmed_positive", "reaction_summary": "Constructive news tone is being confirmed by positive weekly price action.", "reaction_tone": "positive", "trend_label": "Trend inactive", "one_week_move": 3.4, "four_week_move": -0.8, "fair_value_gap": 42.5, "url": "/sentiment/7db6254f-478f-428b-9188-253a56f5a3d8/", "chart_url": "/terminal/7db6254f-478f-428b-9188-253a56f5a3d8/", "sector_url": "/structure/us/industrials/", "industry_url": "/structure/us/industrials/specialty-business-services/"}, {"uuid": "6ee70459-e1c3-4364-b444-7f0c5d886ba0", "symbol": "C1TA34", "name": "Cintas Corporation", "score": 64, "tone": "positive", "country": "BR", "exchange": "SAO", "market": {"country_code": "BR", "country": "Brazil", "flag": "\ud83c\udde7\ud83c\uddf7", "exchange": "SAO", "url": "/listings/?exchange=SAO", "label": "SAO \u00b7 Brazil", "aria": "Open SAO exchange listings for Brazil"}, "sector": "Industrials", "industry": "Specialty Business Services", "headline": "Cintas (CTAS)\u2019s Strong Quarter Is Clear. The Valuation Is the Harder Question", "source": "finance.yahoo.com", "articles": 24, "total_matched": 24, "story_count": 24, "direct_articles": 24, "direct_share": 78, "confidence": 40, "confidence_label": "building confidence", "effective_articles": 6.88, "dispersion": 12, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-29T00:51:43.619Z", "weight": 1.0448, "event_label": "Earnings", "reaction_label": "Balanced read", "reaction_class": "balanced", "reaction_summary": "News tone and price action are not far from neutral.", "reaction_tone": "neutral", "trend_label": "Trend active", "one_week_move": 0.0, "four_week_move": 0.0, "fair_value_gap": 3.3, "url": "/sentiment/6ee70459-e1c3-4364-b444-7f0c5d886ba0/", "chart_url": "/terminal/6ee70459-e1c3-4364-b444-7f0c5d886ba0/", "sector_url": "/structure/br/industrials/", "industry_url": "/structure/br/industrials/specialty-business-services/"}], "score_start": 50, "score_width": 15.599999999999994, "composition": [{"tone": "negative", "label": "Cautious", "count": 0, "share": 0.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 5, "share": 100.0}], "is_current": false}, {"label": "Staffing & Employment Services", "raw_label": "Staffing & Employment Services", "score": 64.0, "average_score": 64.0, "confidence": 37, "confidence_label": "thin evidence", "tone": "positive", "bar": 64.0, "count": 1, "issuer_count": 1, "universe_count": 145, "coverage": 1, "coverage_display": "0.7", "articles": 21, "direct_articles": 21, "source_count": 7, "positive": 1, "neutral": 0, "negative": 0, "latest": "2026-09-28T01:14:28.969Z", "weight": 0.73, "signal_strength": 28, "direct_share": 100, "confirmed": 0, "disagreement": 0, "absorbed": 0, "stretch_risk": 0, "quality": "single-company sample", "url": "/global/sectors/industrials/staffing-employment-services/", "detail_url": "/sentiment/industries/staffing-employment-services/", "ticker_snapshot_ids": [2546240], "tickers": [{"uuid": "49fbb4fc-a531-42a2-ba1d-ab9e0f785c1c", "symbol": "STEM", "name": "SThree plc", "score": 64, "tone": "positive", "country": "GB", "exchange": "LSE", "market": {"country_code": "GB", "country": "United Kingdom", "flag": "\ud83c\uddec\ud83c\udde7", "exchange": "LSE", "url": "/listings/?exchange=LSE", "label": "LSE \u00b7 United Kingdom", "aria": "Open LSE exchange listings for United Kingdom"}, "sector": "Industrials", "industry": "Staffing & Employment Services", "headline": "Form 8.5 (EPT/RI)-SThree plc", "source": "finance.yahoo.com", "articles": 21, "total_matched": 21, "story_count": 21, "direct_articles": 21, "direct_share": 100, "confidence": 39, "confidence_label": "thin evidence", "effective_articles": 6.77, "dispersion": 4, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-28T01:14:28.969Z", "weight": 0.7266, "event_label": "Earnings", "reaction_label": "Balanced read", "reaction_class": "balanced", "reaction_summary": "News tone and price action are not far from neutral.", "reaction_tone": "neutral", "trend_label": "Trend active", "one_week_move": 0.7, "four_week_move": 0.3, "fair_value_gap": 5.2, "url": "/sentiment/49fbb4fc-a531-42a2-ba1d-ab9e0f785c1c/", "chart_url": "/terminal/49fbb4fc-a531-42a2-ba1d-ab9e0f785c1c/", "sector_url": "/structure/gb/industrials/", "industry_url": "/structure/gb/industrials/staffing-employment-services/"}], "score_start": 50, "score_width": 14.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 0, "share": 0.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 1, "share": 100.0}], "is_current": false}, {"label": "Oil & Gas E&P", "raw_label": "Oil & Gas E&P", "score": 63.0, "average_score": 63.0, "confidence": 40, "confidence_label": "building confidence", "tone": "positive", "bar": 63.0, "count": 1, "issuer_count": 1, "universe_count": 342, "coverage": 0, "coverage_display": "0.3", "articles": 75, "direct_articles": 75, "source_count": 13, "positive": 1, "neutral": 0, "negative": 0, "latest": "2026-09-28T10:41:10.553Z", "weight": 0.86, "signal_strength": 26, "direct_share": 100, "confirmed": 0, "disagreement": 1, "absorbed": 0, "stretch_risk": 0, "quality": "single-company sample", "url": "/global/sectors/energy/oil-gas-ep/", "detail_url": "/sentiment/industries/oil-gas-ep/", "ticker_snapshot_ids": [2565444], "tickers": [{"uuid": "ac06a482-1044-442a-8c72-02be76bf204a", "symbol": "FANG", "name": "Diamondback Energy Inc", "score": 63, "tone": "positive", "country": "US", "exchange": "NASDAQ", "market": {"country_code": "US", "country": "United States", "flag": "\ud83c\uddfa\ud83c\uddf8", "exchange": "NASDAQ", "url": "/listings/?exchange=NASDAQ", "label": "NASDAQ \u00b7 United States", "aria": "Open NASDAQ exchange listings for United States"}, "sector": "Energy", "industry": "Oil & Gas E&P", "headline": "Diamondback Energy, Inc. (FANG) Stock Price, News, Quote & History", "source": "Yahoo! Finance Canada", "articles": 75, "total_matched": 75, "story_count": 75, "direct_articles": 75, "direct_share": 100, "confidence": 43, "confidence_label": "building confidence", "effective_articles": 8.47, "dispersion": 16, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-28T10:41:10.553Z", "weight": 0.8551, "event_label": "Earnings", "reaction_label": "Positive news being faded", "reaction_class": "positive_rejected", "reaction_summary": "Constructive headlines are not being rewarded by price, which raises a rejection flag.", "reaction_tone": "negative", "trend_label": "Trend active", "one_week_move": -3.0, "four_week_move": -5.6, "fair_value_gap": 13.7, "url": "/sentiment/ac06a482-1044-442a-8c72-02be76bf204a/", "chart_url": "/terminal/ac06a482-1044-442a-8c72-02be76bf204a/", "sector_url": "/structure/us/energy/", "industry_url": "/structure/us/energy/oil-gas-ep/"}], "score_start": 50, "score_width": 13.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 0, "share": 0.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 1, "share": 100.0}], "is_current": false}, {"label": "Electronics & Computer Distribution", "raw_label": "Electronics & Computer Distribution", "score": 60.0, "average_score": 60.0, "confidence": 50, "confidence_label": "building confidence", "tone": "positive", "bar": 60.0, "count": 1, "issuer_count": 1, "universe_count": 172, "coverage": 1, "coverage_display": "0.6", "articles": 50, "direct_articles": 50, "source_count": 17, "positive": 1, "neutral": 0, "negative": 0, "latest": "2026-09-28T21:31:22.251Z", "weight": 1.14, "signal_strength": 20, "direct_share": 100, "confirmed": 0, "disagreement": 1, "absorbed": 0, "stretch_risk": 1, "quality": "single-company sample", "url": "/global/sectors/technology/electronics-computer-distribution/", "detail_url": "/sentiment/industries/electronics-computer-distribution/", "ticker_snapshot_ids": [2585090], "tickers": [{"uuid": "d378876f-14f7-4d50-9988-c0bf4e793105", "symbol": "SNX", "name": "Synnex Corporation", "score": 60, "tone": "positive", "country": "US", "exchange": "NYSE", "market": {"country_code": "US", "country": "United States", "flag": "\ud83c\uddfa\ud83c\uddf8", "exchange": "NYSE", "url": "/listings/?exchange=NYSE", "label": "NYSE \u00b7 United States", "aria": "Open NYSE exchange listings for United States"}, "sector": "Technology", "industry": "Electronics & Computer Distribution", "headline": "TD SYNNEX (SNX) Posted Strong Third Quarter Results, Is The Stock Still Cheap?", "source": "finance.yahoo.com", "articles": 50, "total_matched": 50, "story_count": 50, "direct_articles": 50, "direct_share": 97, "confidence": 54, "confidence_label": "building confidence", "effective_articles": 10.65, "dispersion": 16, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v11", "collected_at": "2026-09-28T21:31:22.251Z", "weight": 1.1397, "event_label": "Earnings", "reaction_label": "Positive news being faded", "reaction_class": "positive_rejected", "reaction_summary": "Constructive headlines are not being rewarded by price, which raises a rejection flag.", "reaction_tone": "negative", "trend_label": "Trend active", "one_week_move": -1.2, "four_week_move": 3.6, "fair_value_gap": 81.1, "url": "/sentiment/d378876f-14f7-4d50-9988-c0bf4e793105/", "chart_url": "/terminal/d378876f-14f7-4d50-9988-c0bf4e793105/", "sector_url": "/structure/us/technology/", "industry_url": "/structure/us/technology/electronics-computer-distribution/"}], "score_start": 50, "score_width": 10.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 0, "share": 0.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 1, "share": 100.0}], "is_current": false}, {"label": "Oil & Gas Equipment & Services", "raw_label": "Oil & Gas Equipment & Services", "score": 46.4, "average_score": 47.7, "confidence": 48, "confidence_label": "building confidence", "tone": "neutral", "bar": 46.4, "count": 3, "issuer_count": 3, "universe_count": 211, "coverage": 1, "coverage_display": "1.4", "articles": 100, "direct_articles": 100, "source_count": 33, "positive": 0, "neutral": 2, "negative": 1, "latest": "2026-09-29T02:43:56.385Z", "weight": 3.01, "signal_strength": 7, "direct_share": 100, "confirmed": 1, "disagreement": 1, "absorbed": 0, "stretch_risk": 0, "quality": "limited company sample", "url": "/global/sectors/energy/oil-gas-equipment-services/", "detail_url": "/sentiment/industries/oil-gas-equipment-services/", "ticker_snapshot_ids": [2595320, 2580630, 2571936], "tickers": [], "score_start": 46.4, "score_width": 3.6000000000000014, "composition": [{"tone": "negative", "label": "Cautious", "count": 1, "share": 33.33}, {"tone": "neutral", "label": "Balanced", "count": 2, "share": 66.67}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}, {"label": "Medical Devices", "raw_label": "Medical Devices", "score": 46.2, "average_score": 46.2, "confidence": 48, "confidence_label": "building confidence", "tone": "neutral", "bar": 46.2, "count": 9, "issuer_count": 8, "universe_count": 465, "coverage": 2, "coverage_display": "1.9", "articles": 650, "direct_articles": 650, "source_count": 195, "positive": 1, "neutral": 5, "negative": 3, "latest": "2026-09-29T02:08:03.186Z", "weight": 7.64, "signal_strength": 8, "direct_share": 100, "confirmed": 2, "disagreement": 1, "absorbed": 1, "stretch_risk": 0, "quality": "active company-news evidence", "url": "/global/sectors/healthcare/medical-devices/", "detail_url": "/sentiment/industries/medical-devices/", "ticker_snapshot_ids": [2591568, 2560386, 2582080, 2578395, 2594042, 2571412], "tickers": [], "score_start": 46.2, "score_width": 3.799999999999997, "composition": [{"tone": "negative", "label": "Cautious", "count": 3, "share": 33.33}, {"tone": "neutral", "label": "Balanced", "count": 5, "share": 55.56}, {"tone": "positive", "label": "Constructive", "count": 1, "share": 11.11}], "is_current": false}, {"label": "Biotechnology", "raw_label": "Biotechnology", "score": 46.0, "average_score": 45.5, "confidence": 49, "confidence_label": "building confidence", "tone": "neutral", "bar": 46.0, "count": 18, "issuer_count": 18, "universe_count": 1189, "coverage": 2, "coverage_display": "1.5", "articles": 758, "direct_articles": 758, "source_count": 227, "positive": 5, "neutral": 3, "negative": 10, "latest": "2026-09-29T03:12:29.583Z", "weight": 15.65, "signal_strength": 8, "direct_share": 100, "confirmed": 10, "disagreement": 2, "absorbed": 0, "stretch_risk": 4, "quality": "active company-news evidence", "url": "/global/sectors/healthcare/biotechnology/", "detail_url": "/sentiment/industries/biotechnology/", "ticker_snapshot_ids": [2591452, 2558215, 2538290, 2591328, 2557990, 2557431], "tickers": [], "score_start": 46.0, "score_width": 4.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 10, "share": 55.56}, {"tone": "neutral", "label": "Balanced", "count": 3, "share": 16.67}, {"tone": "positive", "label": "Constructive", "count": 5, "share": 27.78}], "is_current": true}, {"label": "Apparel Retail", "raw_label": "Apparel Retail", "score": 46.0, "average_score": 46.0, "confidence": 44, "confidence_label": "building confidence", "tone": "neutral", "bar": 46.0, "count": 5, "issuer_count": 5, "universe_count": 151, "coverage": 3, "coverage_display": "3.3", "articles": 373, "direct_articles": 373, "source_count": 107, "positive": 0, "neutral": 4, "negative": 1, "latest": "2026-09-29T01:30:39.287Z", "weight": 4.6, "signal_strength": 8, "direct_share": 100, "confirmed": 0, "disagreement": 4, "absorbed": 1, "stretch_risk": 0, "quality": "active company-news evidence", "url": "/global/sectors/consumer-cyclical/apparel-retail/", "detail_url": "/sentiment/industries/apparel-retail/", "ticker_snapshot_ids": [2592612, 2583073, 2535785, 2562272, 2579297], "tickers": [], "score_start": 46.0, "score_width": 4.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 1, "share": 20.0}, {"tone": "neutral", "label": "Balanced", "count": 4, "share": 80.0}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}, {"label": "Steel", "raw_label": "Steel", "score": 45.3, "average_score": 45.3, "confidence": 43, "confidence_label": "building confidence", "tone": "neutral", "bar": 45.3, "count": 4, "issuer_count": 3, "universe_count": 490, "coverage": 1, "coverage_display": "0.8", "articles": 202, "direct_articles": 202, "source_count": 68, "positive": 0, "neutral": 4, "negative": 0, "latest": "2026-09-29T03:57:27.243Z", "weight": 3.07, "signal_strength": 9, "direct_share": 100, "confirmed": 0, "disagreement": 0, "absorbed": 0, "stretch_risk": 0, "quality": "limited company sample", "url": "/global/sectors/basic-materials/steel/", "detail_url": "/sentiment/industries/steel/", "ticker_snapshot_ids": [2584136, 2572153, 2568488, 2597693], "tickers": [], "score_start": 45.3, "score_width": 4.700000000000003, "composition": [{"tone": "negative", "label": "Cautious", "count": 0, "share": 0.0}, {"tone": "neutral", "label": "Balanced", "count": 4, "share": 100.0}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}, {"label": "Health Information Services", "raw_label": "Health Information Services", "score": 35.2, "average_score": 35.5, "confidence": 47, "confidence_label": "building confidence", "tone": "negative", "bar": 35.2, "count": 2, "issuer_count": 2, "universe_count": 171, "coverage": 1, "coverage_display": "1.2", "articles": 45, "direct_articles": 45, "source_count": 18, "positive": 0, "neutral": 0, "negative": 2, "latest": "2026-09-29T02:08:40.426Z", "weight": 1.63, "signal_strength": 30, "direct_share": 100, "confirmed": 1, "disagreement": 0, "absorbed": 0, "stretch_risk": 0, "quality": "limited company sample", "url": "/global/sectors/healthcare/health-information-services/", "detail_url": "/sentiment/industries/health-information-services/", "ticker_snapshot_ids": [2594069, 2584350], "tickers": [], "score_start": 35.2, "score_width": 14.799999999999997, "composition": [{"tone": "negative", "label": "Cautious", "count": 2, "share": 100.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}, {"label": "Education & Training Services", "raw_label": "Education & Training Services", "score": 34.0, "average_score": 34.0, "confidence": 55, "confidence_label": "building confidence", "tone": "negative", "bar": 34.0, "count": 1, "issuer_count": 1, "universe_count": 205, "coverage": 0, "coverage_display": "0.5", "articles": 23, "direct_articles": 23, "source_count": 9, "positive": 0, "neutral": 0, "negative": 1, "latest": "2026-09-28T01:37:06.253Z", "weight": 0.86, "signal_strength": 32, "direct_share": 100, "confirmed": 1, "disagreement": 0, "absorbed": 0, "stretch_risk": 0, "quality": "single-company sample", "url": "/global/sectors/consumer-defensive/education-training-services/", "detail_url": "/sentiment/industries/education-training-services/", "ticker_snapshot_ids": [2547022], "tickers": [], "score_start": 34.0, "score_width": 16.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 1, "share": 100.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}, {"label": "Publishing", "raw_label": "Publishing", "score": 33.0, "average_score": 33.0, "confidence": 58, "confidence_label": "building confidence", "tone": "negative", "bar": 33.0, "count": 1, "issuer_count": 1, "universe_count": 133, "coverage": 1, "coverage_display": "0.8", "articles": 46, "direct_articles": 46, "source_count": 16, "positive": 0, "neutral": 0, "negative": 1, "latest": "2026-09-28T11:18:55.833Z", "weight": 1.16, "signal_strength": 34, "direct_share": 100, "confirmed": 1, "disagreement": 0, "absorbed": 0, "stretch_risk": 0, "quality": "single-company sample", "url": "/global/sectors/communication-services/publishing/", "detail_url": "/sentiment/industries/publishing/", "ticker_snapshot_ids": [2566683], "tickers": [], "score_start": 33.0, "score_width": 17.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 1, "share": 100.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}, {"label": "Utilities - Renewable", "raw_label": "Utilities - Renewable", "score": 32.0, "average_score": 32.0, "confidence": 46, "confidence_label": "building confidence", "tone": "negative", "bar": 32.0, "count": 1, "issuer_count": 1, "universe_count": 275, "coverage": 0, "coverage_display": "0.4", "articles": 58, "direct_articles": 58, "source_count": 17, "positive": 0, "neutral": 0, "negative": 1, "latest": "2026-09-28T15:05:06.572Z", "weight": 0.88, "signal_strength": 36, "direct_share": 100, "confirmed": 0, "disagreement": 0, "absorbed": 1, "stretch_risk": 0, "quality": "single-company sample", "url": "/global/sectors/utilities/utilities-renewable/", "detail_url": "/sentiment/industries/utilities-renewable/", "ticker_snapshot_ids": [2574135], "tickers": [], "score_start": 32.0, "score_width": 18.0, "composition": [{"tone": "negative", "label": "Cautious", "count": 1, "share": 100.0}, {"tone": "neutral", "label": "Balanced", "count": 0, "share": 0.0}, {"tone": "positive", "label": "Constructive", "count": 0, "share": 0.0}], "is_current": false}], "show_peer_comparison": true, "show_parent_context": true, "parent_label": "Healthcare", "parent_score": 49.9, "parent_delta": -3.9, "parent_url": "/sentiment/sectors/healthcare/", "market_structure_url": "/global/sectors/healthcare/biotechnology/", "leaders": [{"uuid": "85cf1839-5d87-4b1b-8118-600d01682cf0", "symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "score": 64, "tone": "positive", "headline": "Could Vertex Pharmaceuticals (VRTX)\u2019s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?", "source": "finance.yahoo.com", "articles": 76, "direct_articles": 76, "direct_share": 95, "confidence": 47, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 3.5, "four_week_move": -2.9, "url": "/sentiment/85cf1839-5d87-4b1b-8118-600d01682cf0/", "collected_at": "2026-09-29T00:54:34.974Z"}, {"uuid": "0511ee57-f7cb-417c-b694-04777a2c39f1", "symbol": "SRRK", "name": "Scholar Rock Holding Corp", "score": 60, "tone": "positive", "headline": "FDA Approval Might Shift The Case For Scholar Rock Stock (SRRK)", "source": "simplywall.st", "articles": 40, "direct_articles": 40, "direct_share": 98, "confidence": 37, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 4.2, "four_week_move": -15.9, "url": "/sentiment/0511ee57-f7cb-417c-b694-04777a2c39f1/", "collected_at": "2026-09-28T07:02:10.820Z"}, {"uuid": "bd1f2e80-d7b2-4154-9e21-3c958a3f5103", "symbol": "MESO", "name": "Mesoblast Ltd", "score": 59, "tone": "positive", "headline": "Has Mesoblast (ASX:MSB) cleared a key FDA manufacturing hurdle?", "source": "Kalkine Media", "articles": 12, "direct_articles": 12, "direct_share": 96, "confidence": 43, "event_label": "Regulatory and legal", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.1, "four_week_move": -13.3, "url": "/sentiment/bd1f2e80-d7b2-4154-9e21-3c958a3f5103/", "collected_at": "2026-09-29T00:47:40.942Z"}, {"uuid": "86a31fb0-b9c6-4524-b036-38f4458324ed", "symbol": "AXSM", "name": "Axsome Therapeutics Inc", "score": 59, "tone": "positive", "headline": "Is Axsome Therapeutics (AXSM) Undervalued As Caregiver Survey Data Tests Its CNS Growth Story?", "source": "simplywall.st", "articles": 55, "direct_articles": 55, "direct_share": 98, "confidence": 40, "event_label": "Market update", "reaction_label": "Positive news being faded", "reaction_tone": "negative", "one_week_move": -6.1, "four_week_move": -2.0, "url": "/sentiment/86a31fb0-b9c6-4524-b036-38f4458324ed/", "collected_at": "2026-09-27T19:57:03.937Z"}, {"uuid": "8525148b-d546-4fd1-85af-bbb689255bd7", "symbol": "MRNA", "name": "Moderna Inc", "score": 58, "tone": "positive", "headline": "Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem", "source": "GuruFocus", "articles": 113, "direct_articles": 113, "direct_share": 87, "confidence": 36, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 29.1, "four_week_move": 44.1, "url": "/sentiment/8525148b-d546-4fd1-85af-bbb689255bd7/", "collected_at": "2026-09-28T06:55:22.592Z"}, {"uuid": "4dfa9c09-41c9-47e1-b28d-824cd07172c3", "symbol": "RARE", "name": "Ultragenyx", "score": 56, "tone": "neutral", "headline": "Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $34.58 According to Analysts", "source": "MarketBeat", "articles": 56, "direct_articles": 56, "direct_share": 95, "confidence": 47, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.1, "four_week_move": -43.4, "url": "/sentiment/4dfa9c09-41c9-47e1-b28d-824cd07172c3/", "collected_at": "2026-09-28T06:39:29.270Z"}, {"uuid": "da05e924-2410-4fdc-ae9c-7a87bb611124", "symbol": "INCY", "name": "Incyte Corporation", "score": 55, "tone": "neutral", "headline": "Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment", "source": "finance.yahoo.com", "articles": 56, "direct_articles": 56, "direct_share": 89, "confidence": 36, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -1.1, "four_week_move": -0.4, "url": "/sentiment/da05e924-2410-4fdc-ae9c-7a87bb611124/", "collected_at": "2026-09-28T19:21:18.780Z"}, {"uuid": "ba66de50-b4c5-4885-b13b-b8302704ca4b", "symbol": "VKTX", "name": "Viking Therapeutics Inc", "score": 54, "tone": "neutral", "headline": "Viking Therapeutics (VKTX) Delivers Great VK2735 Results: Here's a Word of Caution", "source": "Motley Fool", "articles": 70, "direct_articles": 70, "direct_share": 92, "confidence": 38, "event_label": "Market update", "reaction_label": "Price moving ahead of tone", "reaction_tone": "positive", "one_week_move": 22.7, "four_week_move": 10.6, "url": "/sentiment/ba66de50-b4c5-4885-b13b-b8302704ca4b/", "collected_at": "2026-09-28T09:35:11.559Z"}], "laggards": [{"uuid": "562bd783-95eb-426a-b811-736b87be555b", "symbol": "AARD", "name": "Aardvark Therapeutics, Inc. Common Stock", "score": 31, "tone": "negative", "headline": "Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm", "source": "Carroll County Mirror-Democrat", "articles": 28, "direct_articles": 28, "direct_share": 100, "confidence": 59, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -5.9, "four_week_move": -12.6, "url": "/sentiment/562bd783-95eb-426a-b811-736b87be555b/", "collected_at": "2026-09-29T03:12:29.583Z"}, {"uuid": "c293609b-7203-452c-9f0a-7f8bc7bfa84d", "symbol": "ARDX", "name": "Ardelyx Inc", "score": 32, "tone": "negative", "headline": "Uncovering Potential: Penny Stocks To Watch In September 2026", "source": "webull.com", "articles": 21, "direct_articles": 21, "direct_share": 100, "confidence": 63, "event_label": "Regulatory and legal", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": 0.0, "four_week_move": -10.2, "url": "/sentiment/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "collected_at": "2026-09-28T04:51:29.623Z"}, {"uuid": "f2d8b40b-4f13-47b3-8175-933f14f78530", "symbol": "GUTS", "name": "Fractyl Health, Inc. Common Stock", "score": 32, "tone": "negative", "headline": "Fractyl Health faces lawsuit over alleged false claims about therapy effectiveness.", "source": "Pluang", "articles": 28, "direct_articles": 28, "direct_share": 100, "confidence": 61, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -19.1, "four_week_move": -26.3, "url": "/sentiment/f2d8b40b-4f13-47b3-8175-933f14f78530/", "collected_at": "2026-09-29T01:08:43.492Z"}, {"uuid": "231006cc-9a48-40d6-9ca0-a344e86c847d", "symbol": "UNCY", "name": "Unicycive Therapeutics Inc", "score": 35, "tone": "negative", "headline": "Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026", "source": "The Globe and Mail", "articles": 20, "direct_articles": 20, "direct_share": 100, "confidence": 58, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -2.2, "four_week_move": -10.8, "url": "/sentiment/231006cc-9a48-40d6-9ca0-a344e86c847d/", "collected_at": "2026-09-28T02:14:30.618Z"}, {"uuid": "1e14fcdc-fe5f-4434-aa02-d06cd5381218", "symbol": "SPRY", "name": "ARS Pharmaceuticals, Inc", "score": 35, "tone": "negative", "headline": "Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm Before Lead Plaintiff Deadline on October 5, 2026", "source": "The National Law Review", "articles": 14, "direct_articles": 14, "direct_share": 100, "confidence": 50, "event_label": "Regulatory and legal", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.7, "four_week_move": -30.7, "url": "/sentiment/1e14fcdc-fe5f-4434-aa02-d06cd5381218/", "collected_at": "2026-09-28T12:08:43.193Z"}, {"uuid": "e2b47bef-4e47-4d5a-b1b8-a7d99654827c", "symbol": "CAPR", "name": "Capricor Therapeutics Inc", "score": 36, "tone": "negative", "headline": "Investors in Capricor Therapeutics, Inc. (CAPR): Protect Your Rights - Contact Levi & Korsinsky Before September 28, 2026", "source": "ACCESS Newswire", "articles": 31, "direct_articles": 31, "direct_share": 100, "confidence": 51, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -7.7, "four_week_move": -12.8, "url": "/sentiment/e2b47bef-4e47-4d5a-b1b8-a7d99654827c/", "collected_at": "2026-09-28T07:36:43.696Z"}, {"uuid": "02f63602-b4a8-4c7c-9f61-de7535f8755d", "symbol": "REPL", "name": "Replimune Group Inc", "score": 36, "tone": "negative", "headline": "Lost Money on Replimune Group, Inc. (REPL)? Urged to Join Class Action Before October 5, 2026 \u2013 Contact Levi & Korsinsky", "source": "ACCESS Newswire", "articles": 19, "direct_articles": 19, "direct_share": 100, "confidence": 50, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -5.4, "four_week_move": -20.3, "url": "/sentiment/02f63602-b4a8-4c7c-9f61-de7535f8755d/", "collected_at": "2026-09-28T06:52:54.638Z"}, {"uuid": "fea6d02a-3fdd-4ea7-afb9-c0a519eabacf", "symbol": "CLLS", "name": "Cellectis SA", "score": 36, "tone": "negative", "headline": "Bronstein, Gewirtz & Grossman, LLC Encourages Cellectis S.A. (CLLS) Stockholders to Inquire about Securities Investigation", "source": "The National Law Review", "articles": 28, "direct_articles": 28, "direct_share": 100, "confidence": 42, "event_label": "Market update", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -3.9, "four_week_move": -56.8, "url": "/sentiment/fea6d02a-3fdd-4ea7-afb9-c0a519eabacf/", "collected_at": "2026-09-28T06:09:42.673Z"}], "attention": [{"uuid": "8525148b-d546-4fd1-85af-bbb689255bd7", "symbol": "MRNA", "name": "Moderna Inc", "score": 58, "tone": "positive", "headline": "Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem", "source": "GuruFocus", "articles": 113, "direct_articles": 113, "direct_share": 87, "confidence": 36, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 29.1, "four_week_move": 44.1, "url": "/sentiment/8525148b-d546-4fd1-85af-bbb689255bd7/", "collected_at": "2026-09-28T06:55:22.592Z"}, {"uuid": "85cf1839-5d87-4b1b-8118-600d01682cf0", "symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "score": 64, "tone": "positive", "headline": "Could Vertex Pharmaceuticals (VRTX)\u2019s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?", "source": "finance.yahoo.com", "articles": 76, "direct_articles": 76, "direct_share": 95, "confidence": 47, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 3.5, "four_week_move": -2.9, "url": "/sentiment/85cf1839-5d87-4b1b-8118-600d01682cf0/", "collected_at": "2026-09-29T00:54:34.974Z"}, {"uuid": "ba66de50-b4c5-4885-b13b-b8302704ca4b", "symbol": "VKTX", "name": "Viking Therapeutics Inc", "score": 54, "tone": "neutral", "headline": "Viking Therapeutics (VKTX) Delivers Great VK2735 Results: Here's a Word of Caution", "source": "Motley Fool", "articles": 70, "direct_articles": 70, "direct_share": 92, "confidence": 38, "event_label": "Market update", "reaction_label": "Price moving ahead of tone", "reaction_tone": "positive", "one_week_move": 22.7, "four_week_move": 10.6, "url": "/sentiment/ba66de50-b4c5-4885-b13b-b8302704ca4b/", "collected_at": "2026-09-28T09:35:11.559Z"}, {"uuid": "1c42d613-c405-45d7-9f43-f2050c317cb4", "symbol": "REGN", "name": "Regeneron Pharmaceuticals Inc", "score": 42, "tone": "negative", "headline": "Regeneron to Report Third Quarter 2026 Financial and\u00a0Operating Results and Host Conference Call and Webcast on October 30, 2026", "source": "GlobeNewswire", "articles": 59, "direct_articles": 59, "direct_share": 100, "confidence": 43, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": 0.4, "four_week_move": -0.8, "url": "/sentiment/1c42d613-c405-45d7-9f43-f2050c317cb4/", "collected_at": "2026-09-27T18:48:13.140Z"}, {"uuid": "4dfa9c09-41c9-47e1-b28d-824cd07172c3", "symbol": "RARE", "name": "Ultragenyx", "score": 56, "tone": "neutral", "headline": "Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $34.58 According to Analysts", "source": "MarketBeat", "articles": 56, "direct_articles": 56, "direct_share": 95, "confidence": 47, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.1, "four_week_move": -43.4, "url": "/sentiment/4dfa9c09-41c9-47e1-b28d-824cd07172c3/", "collected_at": "2026-09-28T06:39:29.270Z"}, {"uuid": "da05e924-2410-4fdc-ae9c-7a87bb611124", "symbol": "INCY", "name": "Incyte Corporation", "score": 55, "tone": "neutral", "headline": "Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment", "source": "finance.yahoo.com", "articles": 56, "direct_articles": 56, "direct_share": 89, "confidence": 36, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -1.1, "four_week_move": -0.4, "url": "/sentiment/da05e924-2410-4fdc-ae9c-7a87bb611124/", "collected_at": "2026-09-28T19:21:18.780Z"}, {"uuid": "86a31fb0-b9c6-4524-b036-38f4458324ed", "symbol": "AXSM", "name": "Axsome Therapeutics Inc", "score": 59, "tone": "positive", "headline": "Is Axsome Therapeutics (AXSM) Undervalued As Caregiver Survey Data Tests Its CNS Growth Story?", "source": "simplywall.st", "articles": 55, "direct_articles": 55, "direct_share": 98, "confidence": 40, "event_label": "Market update", "reaction_label": "Positive news being faded", "reaction_tone": "negative", "one_week_move": -6.1, "four_week_move": -2.0, "url": "/sentiment/86a31fb0-b9c6-4524-b036-38f4458324ed/", "collected_at": "2026-09-27T19:57:03.937Z"}, {"uuid": "0511ee57-f7cb-417c-b694-04777a2c39f1", "symbol": "SRRK", "name": "Scholar Rock Holding Corp", "score": 60, "tone": "positive", "headline": "FDA Approval Might Shift The Case For Scholar Rock Stock (SRRK)", "source": "simplywall.st", "articles": 40, "direct_articles": 40, "direct_share": 98, "confidence": 37, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 4.2, "four_week_move": -15.9, "url": "/sentiment/0511ee57-f7cb-417c-b694-04777a2c39f1/", "collected_at": "2026-09-28T07:02:10.820Z"}], "latest_observations": [{"uuid": "85cf1839-5d87-4b1b-8118-600d01682cf0", "symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "score": 64, "tone": "positive", "headline": "Could Vertex Pharmaceuticals (VRTX)\u2019s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?", "source": "finance.yahoo.com", "articles": 76, "direct_articles": 76, "direct_share": 95, "confidence": 47, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 3.5, "four_week_move": -2.9, "url": "/sentiment/85cf1839-5d87-4b1b-8118-600d01682cf0/", "collected_at": "2026-09-29T00:54:34.974Z"}, {"uuid": "da05e924-2410-4fdc-ae9c-7a87bb611124", "symbol": "INCY", "name": "Incyte Corporation", "score": 55, "tone": "neutral", "headline": "Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment", "source": "finance.yahoo.com", "articles": 56, "direct_articles": 56, "direct_share": 89, "confidence": 36, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -1.1, "four_week_move": -0.4, "url": "/sentiment/da05e924-2410-4fdc-ae9c-7a87bb611124/", "collected_at": "2026-09-28T19:21:18.780Z"}, {"uuid": "bd1f2e80-d7b2-4154-9e21-3c958a3f5103", "symbol": "MESO", "name": "Mesoblast Ltd", "score": 59, "tone": "positive", "headline": "Has Mesoblast (ASX:MSB) cleared a key FDA manufacturing hurdle?", "source": "Kalkine Media", "articles": 12, "direct_articles": 12, "direct_share": 96, "confidence": 43, "event_label": "Regulatory and legal", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.1, "four_week_move": -13.3, "url": "/sentiment/bd1f2e80-d7b2-4154-9e21-3c958a3f5103/", "collected_at": "2026-09-29T00:47:40.942Z"}, {"uuid": "86a31fb0-b9c6-4524-b036-38f4458324ed", "symbol": "AXSM", "name": "Axsome Therapeutics Inc", "score": 59, "tone": "positive", "headline": "Is Axsome Therapeutics (AXSM) Undervalued As Caregiver Survey Data Tests Its CNS Growth Story?", "source": "simplywall.st", "articles": 55, "direct_articles": 55, "direct_share": 98, "confidence": 40, "event_label": "Market update", "reaction_label": "Positive news being faded", "reaction_tone": "negative", "one_week_move": -6.1, "four_week_move": -2.0, "url": "/sentiment/86a31fb0-b9c6-4524-b036-38f4458324ed/", "collected_at": "2026-09-27T19:57:03.937Z"}, {"uuid": "02f63602-b4a8-4c7c-9f61-de7535f8755d", "symbol": "REPL", "name": "Replimune Group Inc", "score": 36, "tone": "negative", "headline": "Lost Money on Replimune Group, Inc. (REPL)? Urged to Join Class Action Before October 5, 2026 \u2013 Contact Levi & Korsinsky", "source": "ACCESS Newswire", "articles": 19, "direct_articles": 19, "direct_share": 100, "confidence": 50, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -5.4, "four_week_move": -20.3, "url": "/sentiment/02f63602-b4a8-4c7c-9f61-de7535f8755d/", "collected_at": "2026-09-28T06:52:54.638Z"}, {"uuid": "ba66de50-b4c5-4885-b13b-b8302704ca4b", "symbol": "VKTX", "name": "Viking Therapeutics Inc", "score": 54, "tone": "neutral", "headline": "Viking Therapeutics (VKTX) Delivers Great VK2735 Results: Here's a Word of Caution", "source": "Motley Fool", "articles": 70, "direct_articles": 70, "direct_share": 92, "confidence": 38, "event_label": "Market update", "reaction_label": "Price moving ahead of tone", "reaction_tone": "positive", "one_week_move": 22.7, "four_week_move": 10.6, "url": "/sentiment/ba66de50-b4c5-4885-b13b-b8302704ca4b/", "collected_at": "2026-09-28T09:35:11.559Z"}, {"uuid": "8525148b-d546-4fd1-85af-bbb689255bd7", "symbol": "MRNA", "name": "Moderna Inc", "score": 58, "tone": "positive", "headline": "Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem", "source": "GuruFocus", "articles": 113, "direct_articles": 113, "direct_share": 87, "confidence": 36, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 29.1, "four_week_move": 44.1, "url": "/sentiment/8525148b-d546-4fd1-85af-bbb689255bd7/", "collected_at": "2026-09-28T06:55:22.592Z"}, {"uuid": "5a328a8a-6845-40c9-ba0d-5de214bb0a96", "symbol": "ACAD", "name": "ACADIA Pharmaceuticals Inc", "score": 39, "tone": "negative", "headline": "Acadia Pharmaceuticals (ACAD) Stock Trades At A Discount After A 29% Drop", "source": "Simply Wall St.", "articles": 32, "direct_articles": 32, "direct_share": 95, "confidence": 46, "event_label": "Market update", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -24.2, "four_week_move": -29.0, "url": "/sentiment/5a328a8a-6845-40c9-ba0d-5de214bb0a96/", "collected_at": "2026-09-28T17:01:38.430Z"}, {"uuid": "4dfa9c09-41c9-47e1-b28d-824cd07172c3", "symbol": "RARE", "name": "Ultragenyx", "score": 56, "tone": "neutral", "headline": "Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $34.58 According to Analysts", "source": "MarketBeat", "articles": 56, "direct_articles": 56, "direct_share": 95, "confidence": 47, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.1, "four_week_move": -43.4, "url": "/sentiment/4dfa9c09-41c9-47e1-b28d-824cd07172c3/", "collected_at": "2026-09-28T06:39:29.270Z"}, {"uuid": "0511ee57-f7cb-417c-b694-04777a2c39f1", "symbol": "SRRK", "name": "Scholar Rock Holding Corp", "score": 60, "tone": "positive", "headline": "FDA Approval Might Shift The Case For Scholar Rock Stock (SRRK)", "source": "simplywall.st", "articles": 40, "direct_articles": 40, "direct_share": 98, "confidence": 37, "event_label": "Market update", "reaction_label": "News confirmed by price", "reaction_tone": "positive", "one_week_move": 4.2, "four_week_move": -15.9, "url": "/sentiment/0511ee57-f7cb-417c-b694-04777a2c39f1/", "collected_at": "2026-09-28T07:02:10.820Z"}, {"uuid": "fea6d02a-3fdd-4ea7-afb9-c0a519eabacf", "symbol": "CLLS", "name": "Cellectis SA", "score": 36, "tone": "negative", "headline": "Bronstein, Gewirtz & Grossman, LLC Encourages Cellectis S.A. (CLLS) Stockholders to Inquire about Securities Investigation", "source": "The National Law Review", "articles": 28, "direct_articles": 28, "direct_share": 100, "confidence": 42, "event_label": "Market update", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -3.9, "four_week_move": -56.8, "url": "/sentiment/fea6d02a-3fdd-4ea7-afb9-c0a519eabacf/", "collected_at": "2026-09-28T06:09:42.673Z"}, {"uuid": "562bd783-95eb-426a-b811-736b87be555b", "symbol": "AARD", "name": "Aardvark Therapeutics, Inc. Common Stock", "score": 31, "tone": "negative", "headline": "Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm", "source": "Carroll County Mirror-Democrat", "articles": 28, "direct_articles": 28, "direct_share": 100, "confidence": 59, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -5.9, "four_week_move": -12.6, "url": "/sentiment/562bd783-95eb-426a-b811-736b87be555b/", "collected_at": "2026-09-29T03:12:29.583Z"}, {"uuid": "c293609b-7203-452c-9f0a-7f8bc7bfa84d", "symbol": "ARDX", "name": "Ardelyx Inc", "score": 32, "tone": "negative", "headline": "Uncovering Potential: Penny Stocks To Watch In September 2026", "source": "webull.com", "articles": 21, "direct_articles": 21, "direct_share": 100, "confidence": 63, "event_label": "Regulatory and legal", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": 0.0, "four_week_move": -10.2, "url": "/sentiment/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "collected_at": "2026-09-28T04:51:29.623Z"}, {"uuid": "1e14fcdc-fe5f-4434-aa02-d06cd5381218", "symbol": "SPRY", "name": "ARS Pharmaceuticals, Inc", "score": 35, "tone": "negative", "headline": "Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm Before Lead Plaintiff Deadline on October 5, 2026", "source": "The National Law Review", "articles": 14, "direct_articles": 14, "direct_share": 100, "confidence": 50, "event_label": "Regulatory and legal", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": -0.7, "four_week_move": -30.7, "url": "/sentiment/1e14fcdc-fe5f-4434-aa02-d06cd5381218/", "collected_at": "2026-09-28T12:08:43.193Z"}, {"uuid": "e2b47bef-4e47-4d5a-b1b8-a7d99654827c", "symbol": "CAPR", "name": "Capricor Therapeutics Inc", "score": 36, "tone": "negative", "headline": "Investors in Capricor Therapeutics, Inc. (CAPR): Protect Your Rights - Contact Levi & Korsinsky Before September 28, 2026", "source": "ACCESS Newswire", "articles": 31, "direct_articles": 31, "direct_share": 100, "confidence": 51, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -7.7, "four_week_move": -12.8, "url": "/sentiment/e2b47bef-4e47-4d5a-b1b8-a7d99654827c/", "collected_at": "2026-09-28T07:36:43.696Z"}, {"uuid": "231006cc-9a48-40d6-9ca0-a344e86c847d", "symbol": "UNCY", "name": "Unicycive Therapeutics Inc", "score": 35, "tone": "negative", "headline": "Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026", "source": "The Globe and Mail", "articles": 20, "direct_articles": 20, "direct_share": 100, "confidence": 58, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -2.2, "four_week_move": -10.8, "url": "/sentiment/231006cc-9a48-40d6-9ca0-a344e86c847d/", "collected_at": "2026-09-28T02:14:30.618Z"}, {"uuid": "f2d8b40b-4f13-47b3-8175-933f14f78530", "symbol": "GUTS", "name": "Fractyl Health, Inc. Common Stock", "score": 32, "tone": "negative", "headline": "Fractyl Health faces lawsuit over alleged false claims about therapy effectiveness.", "source": "Pluang", "articles": 28, "direct_articles": 28, "direct_share": 100, "confidence": 61, "event_label": "Regulatory and legal", "reaction_label": "Caution confirmed by price", "reaction_tone": "negative", "one_week_move": -19.1, "four_week_move": -26.3, "url": "/sentiment/f2d8b40b-4f13-47b3-8175-933f14f78530/", "collected_at": "2026-09-29T01:08:43.492Z"}, {"uuid": "1c42d613-c405-45d7-9f43-f2050c317cb4", "symbol": "REGN", "name": "Regeneron Pharmaceuticals Inc", "score": 42, "tone": "negative", "headline": "Regeneron to Report Third Quarter 2026 Financial and\u00a0Operating Results and Host Conference Call and Webcast on October 30, 2026", "source": "GlobeNewswire", "articles": 59, "direct_articles": 59, "direct_share": 100, "confidence": 43, "event_label": "Market update", "reaction_label": "Balanced read", "reaction_tone": "neutral", "one_week_move": 0.4, "four_week_move": -0.8, "url": "/sentiment/1c42d613-c405-45d7-9f43-f2050c317cb4/", "collected_at": "2026-09-27T18:48:13.140Z"}], "catalysts": [{"label": "Market update", "count": 10, "share": 55.6, "score": 52.9, "tone": "neutral"}, {"label": "Regulatory and legal", "count": 8, "share": 44.4, "score": 37.4, "tone": "negative"}], "publishers": [{"label": "The National Law Review", "count": 2, "share": 11.1, "score": 35.5, "tone": "negative"}, {"label": "ACCESS Newswire", "count": 2, "share": 11.1, "score": 36.0, "tone": "negative"}, {"label": "finance.yahoo.com", "count": 2, "share": 11.1, "score": 59.8, "tone": "positive"}, {"label": "simplywall.st", "count": 2, "share": 11.1, "score": 59.4, "tone": "positive"}, {"label": "Carroll County Mirror-Democrat", "count": 1, "share": 5.6, "score": 31.0, "tone": "negative"}, {"label": "Pluang", "count": 1, "share": 5.6, "score": 32.0, "tone": "negative"}, {"label": "webull.com", "count": 1, "share": 5.6, "score": 32.0, "tone": "negative"}, {"label": "The Globe and Mail", "count": 1, "share": 5.6, "score": 35.0, "tone": "negative"}], "confirming": ["100% of the stories are tied directly to a company."], "warnings": ["Negative company breadth is 36/100.", "Confidence is 49/100, so this group score should be treated cautiously.", "Only 28% of measured companies had a positive one-week price move."], "latest_updated": "2026-09-29T03:12:29.583Z", "navigation": [{"label": "Overview", "url": "/sentiment/"}, {"label": "Country sentiment", "url": "/sentiment/countries/"}, {"label": "Sector sentiment", "url": "/sentiment/sectors/"}, {"label": "Industry sentiment", "url": "/sentiment/industries/"}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}